Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone.

Circ Rep · 2021 · PMC8180375 · PMID 34136708

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

did not reach statistical significanceP=0.059so close (0.05 < p ≤ 0.1)

In the multivariate analysis, the association of these two variables with any increase in eGFR did not reach statistical significance (P=0.059 and P=0.051 for body surface area and dose of esaxerenone, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.